A “Key Figure” from sanofi-aventis’ annual report:
The title of this post is from one of my favorite Woody Allen movies. Relax: I don’t expect any of you to get that one.
(UPDATE: Summamabitch! sanofi got revenge on me! I was about 80% of the way through its profile, for an issue that goes to press early next week, when I got a pharma e-newsletter with a link to the following item:
Sanofi-Aventis Plans Job Cuts
M2 Europharma – Jun. 22, 2009
22 June 2009 -French pharmaceutical group Sanofi-Aventis (EPA: SAN) may further cut jobs after the 927 lay-offs in 2008, business daily Les Echos reported on Monday (22 June), quoting trade union sources.
Sanofi-Aventis management is expected to announce the plans for major restructuring at an extraordinary works council next week. Employees are particularly concerned over positions in the research divisions.
The drug maker has been affected by the launch of generic versions of some of its key medicines. Within the coming months the generic version of its anti-cancer drug Eloxatin should …
Of course, the full announcement’s only going to come after the company’s profile is off at the printer! Grr!)